Premium
Deletion of V itamin C biosynthesis enzyme, A rabino‐1, 4‐lactone oxidase in L eishmania donovani results in increased pro‐inflammatory responses from host immune cells
Author(s) -
Manhas Reetika,
Anand Sneha,
Tripathi Pankaj,
Madhubala Rentala
Publication year - 2014
Publication title -
molecular microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 247
eISSN - 1365-2958
pISSN - 0950-382X
DOI - 10.1111/mmi.12530
Subject(s) - biology , mutant , ascorbic acid , oxidase test , nadph oxidase , complementation , biochemistry , immune system , enzyme , reactive oxygen species , in vivo , microbiology and biotechnology , tumor necrosis factor alpha , gene , immunology , genetics , food science
Summary Recently, we reported molecular characterization, localization and functional importance of A rabino‐1, 4‐lactone oxidase ( ALO ) enzyme from L eishmania donovani that catalyses the last step in ascorbate biosynthesis pathway. V itamin C ( l ‐ascorbic acid) is implicated in several crucial physiological processes. To elucidate the biological role of d ‐arabinono‐γ‐lactone oxidase in L eishmania , we made L . donovani ALO null mutant (Δ ALO ) by double targeted gene replacement. This mutant lacked ALO activity, showed transient growth defect and reduced ascorbate levels. Δ ALO grown in ascorbate depleted media further enhanced growth defect with no detectable levels of ascorbate, implying that parasites have the ability to scavenge ascorbate. Δ ALO mutants showed reduced survival in mouse macrophages and are impaired in their infectivity in vivo . Furthermore, the Δ ALO mutant induced production of pro‐inflammatory cytokines gamma interferon ( IFN ‐gamma), interleukin‐12 ( IL ‐12) and tumour necrosis factor‐α ( TNF ‐α) by infected mouse macrophages. These mutants were susceptible to oxidative stresses in vitro as revealed by the decreased survival inside macrophages by increased production of reactive oxygen or nitrogen species. Complementation of the Δ ALO mutants restored the phenotypic effects in these parasites. Our description of ALO null mutant parasite that triggers pro‐inflammatory host responses provides a novel platform for targeting ALO in anti‐parasitic strategies.